Rational Design of Peptide Vaccines Against Multiple Types of Human Papillomavirus.

about

Epitope design of L1 protein for vaccine production against Human Papilloma Virus types 16 and 18 Immune-Informatic Analysis and Design of Peptide Vaccine From Multi-epitopes Against Corynebacterium pseudotuberculosis.

P2860

Q33743226-8C28D6B6-8CE7-48E3-BC58-C10F007496EF Q55107001-43724983-53A1-4D76-8892-421D226250B8

P2860

Rational Design of Peptide Vaccines Against Multiple Types of Human Papillomavirus.

Item

http://www.wikidata.org/entity/Q36961621

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Rational Design of Peptide Vaccines Against Multiple Types of Human Papillomavirus.

@en

type

Item

label

Rational Design of Peptide Vaccines Against Multiple Types of Human Papillomavirus.

@en

prefLabel

Rational Design of Peptide Vaccines Against Multiple Types of Human Papillomavirus.

@en

P1476

Rational Design of Peptide Vaccines Against Multiple Types of Human Papillomavirus.

@en

P2093

Antara De

http://www.w3.org/2001/XMLSchema#string

Ashesh Nandy

http://www.w3.org/2001/XMLSchema#string

Sumanta Dey

http://www.w3.org/2001/XMLSchema#string

P2860

Evolution and taxonomic classification of human papillomavirus 16 (HPV16)-related variant genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67

Role of human papillomaviruses in carcinogenesis

Vaccinology in the third millennium: scientific and social challenges

Prophylactic human papillomavirus vaccines

Crystal structures of four types of human papillomavirus L1 capsid proteins: understanding the specificity of neutralizing monoclonal antibodies

Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

The three Es of cancer immunoediting

Against which human papillomavirus types shall we vaccinate and screen? The international perspective

The global health burden of infection-associated cancers in the year 2002

In silico study of rotavirus VP7 surface accessible conserved regions for antiviral drug/vaccine design

P304

1-16

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4137/CIN.S39071

http://www.w3.org/2001/XMLSchema#string

P433

Suppl 1

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27279731

http://www.w3.org/2001/XMLSchema#string

P932

4890726

http://www.w3.org/2001/XMLSchema#string

Rational Design of Peptide Vaccines Against Multiple Types of Human Papillomavirus.

about

P2860

P2860

Rational Design of Peptide Vaccines Against Multiple Types of Human Papillomavirus.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932